Eledon Pharmaceuticals Inc expected to post a loss of 32  cents a share - Earnings Preview

Eledon Pharmaceuticals

11/05/2021 23:02

* Eledon Pharmaceuticals Inc  ELDN.OQ   ELDN.O  is expected
to show a no change in quarterly revenue when it reports
results on May 13 .
​* Refinitiv's mean analyst estimate for Eledon Pharmaceuticals
Inc is for a loss of 32 cents per share. For the same quarter
last year, the company reported a loss of $3.42 per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts had risen by about 9.5%
in the last three months. ​
* Wall Street's median 12-month price target for Eledon
Pharmaceuticals Inc is $32​, about 69.8% above​ its last closing
price of $9.65. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Dec. 31 2020  -0.31       -1.39      -2.12     Missed  -52
 Sep. 30 2020  -1.82       -1.75      -5.51     Missed  -215.5
 Jun. 30 2020  -2.70       -2.97      -2.16     Beat    27.3​
 Mar. 31 2020  -2.86       -2.88      -3.42     Missed  -18.7
 Dec.          -4.66​      -4.68      -3.24     Beat    30.8​
 31​ 2019​                                              
 Sep. 30 2019  -7.38       -7.29      -3.96     Beat    45.7​
 Jun. 30 2019  -7.65       -7.65      -6.30     Beat    17.6
 Mar. 31 2019  -8.74       -8.73      -9.36     Missed  -7.2
 This summary was machine generated May 11 at 22:02 GMT.  All
figures in US dollars unless otherwise stated